The DOI matches its Crossref record; 207 of the 207 references it cites were found in a registry or an index.
Overcoming cancer chemotherapy resistance by the induction of ferroptosis
Abstract
Development of resistance to chemotherapy in cancer continues to be a major challenge in cancer management. Ferroptosis, a unique type of cell death, is mechanistically and morphologically different from other forms of cell death. Ferroptosis plays a pivotal role in inhibiting tumour growth and has presented new opportunities for treatment of chemotherapy-insensitive tumours in recent years. Emerging studies have suggested that ferroptosis can regulate the therapeutic responses of tumours. Accumulating evidence supports ferroptosis as a potential target for chemotherapy resistance. Pharmacological induction of ferroptosis could reverse drug resistance in tumours. In this review article, we first discuss the key principles of chemotherapeutic resistance in cancer. We then provide a brief overview of the core mechanisms of ferroptosis in cancer chemotherapeutic drug resistance. Finally, we summarise the emerging data that supports the fact that chemotherapy resistance in different types of cancers could be subdued by pharmacologically inducing ferroptosis. This review article suggests that pharmacological induction of ferroptosis by bioactive compounds (ferroptosis inducers) could overcome chemotherapeutic drug resistance. This article also highlights some promising therapeutic avenues that could be used to overcome chemotherapeutic drug resistance in cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
CHEN, L., LI, X., LIU, L., YU, B., XUE, Y., & LIU, Y. (2015) · Oncology Reports · doi:10.3892/or.2015.3712 · Cited by 279
RetractedHan, S., Liu, Q., Yang, Z., Ma, J., Liu, D., Yan, C., & Liang, D. (2022) · Disease Markers · doi:10.1155/2022/6400227 · Cited by 10
RetractedFerroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
Dixon, S. J., Lemberg, K. M., Lamprecht, M. R., Skouta, R., Zaitsev, E. M., Gleason, C. E., Patel, D. N., Bauer, A. J., Cantley, A. M., Yang, W. S., et al. (2012) · Cell · doi:10.1016/j.cell.2012.03.042 · Cited by 18,691
Ferroptosis: mechanisms, biology and role in disease
Jiang, X., Stockwell, B. R., & Conrad, M. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-00324-8 · Cited by 7,505
Dekker, E., Tanis, P. J., Vleugels, J. L. A., Kasi, P. M., & Wallace, M. B. (2019) · The Lancet · doi:10.1016/s0140-6736(19)32319-0 · Cited by 4,974
Tumour stem cells and drug resistance
Dean, M., Fojo, T., & Bates, S. (2005) · Nature reviews. Cancer · doi:10.1038/nrc1590 · Cited by 3,668
Ferroptosis as a p53-mediated activity during tumour suppression
Jiang, L., Kon, N., Li, T., Wang, S.-J., Su, T., Hibshoosh, H., Baer, R., & Gu, W. (2015) · Nature · doi:10.1038/nature14344 · Cited by 3,398
Ferroptosis turns 10: Emerging mechanisms, physiological functions, and therapeutic applications
Stockwell, B. R. (2022) · Cell · doi:10.1016/j.cell.2022.06.003 · Cited by 3,056
Broadening horizons: the role of ferroptosis in cancer
Chen, X., Kang, R., Kroemer, G., & Tang, D. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-00462-0 · Cited by 2,897
Mechanisms of Cancer Drug Resistance
Gottesman, M. M. (2002) · Annual Review of Medicine · doi:10.1146/annurev.med.53.082901.103929 · Cited by 2,643
Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy
Koppula, P., Zhuang, L., & Gan, B. (2021) · Protein & Cell · doi:10.1007/s13238-020-00789-5 · Cited by 2,487
NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis
Dodson, M., Castro-Portuguez, R., & Zhang, D. D. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101107 · Cited by 2,435
Autophagy promotes ferroptosis by degradation of ferritin
Hou, W., Xie, Y., Song, X., Sun, X., Lotze, M. T., Zeh, H. J., Kang, R., & Tang, D. (2016) · Autophagy · doi:10.1080/15548627.2016.1187366 · Cited by 2,332
Targeting Ferroptosis as a Vulnerability in Cancer
Lei, G., Zhuang, L., & Gan, B. (2022) · Nature reviews. Cancer · doi:10.1038/s41568-022-00459-0 · Cited by 2,252
Ferroptosis as a target for protection against cardiomyopathy
Fang, X., Wang, H., Han, D., Xie, E., Yang, X., Wei, J., Gu, S., Gao, F., Zhu, N., Yin, X., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1821022116 · Cited by 2,127
Self-citationDixon, S. J., Patel, D. N., Welsch, M., Skouta, R., Lee, E. D., Hayano, M., Thomas, A. G., Gleason, C. E., Tatonetti, N. P., Slusher, B. S., et al. (2014) · eLife · doi:10.7554/elife.02523 · Cited by 2,088
Quantitative proteomics identifies NCOA4 as the cargo receptor mediating ferritinophagy
Mancias, J. D., Wang, X., Gygi, S. P., Harper, J. W., & Kimmelman, A. C. (2014) · Nature · doi:10.1038/nature13148 · Cited by 2,084
Sun, X., Ou, Z., Chen, R., Niu, X., Chen, D., Kang, R., & Tang, D. (2016) · Hepatology · doi:10.1002/hep.28251 · Cited by 2,012
Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway
Viswanathan, V. S., Ryan, M. J., Dhruv, H. D., Gill, S., Eichhoff, O. M., Seashore-Ludlow, B., Kaffenberger, S. D., Eaton, J. K., Shimada, K., Aguirre, A. J., et al. (2017) · Nature · doi:10.1038/nature23007 · Cited by 2,011
Self-citationFerroptosis is an autophagic cell death process
Gao, M., Monian, P., Pan, Q., Zhang, W., Xiang, J., & Jiang, X. (2016) · Cell Research · doi:10.1038/cr.2016.95 · Cited by 1,899
Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition
Hangauer, M. J., Viswanathan, V. S., Ryan, M. J., Bole, D., Eaton, J. K., Matov, A., Galeas, J., Dhruv, H. D., Berens, M. E., Schreiber, S. L., et al. (2017) · Nature · doi:10.1038/nature24297 · Cited by 1,799
Mechanisms of Multidrug Resistance in Cancer Chemotherapy
Bukowski, K., Kciuk, M., & Kontek, R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093233 · Cited by 1,757
Cisplatin: The first metal based anticancer drug
Ghosh, S. (2019) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2019.102925 · Cited by 1,751
NRF2 and the Hallmarks of Cancer
Rojo de la Vega, M., Chapman, E., & Zhang, D. D. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.03.022 · Cited by 1,672
Ferroptosis in cancer therapy: a novel approach to reversing drug resistance
Zhang, C., Liu, X., Jin, S., Chen, Y., & Guo, R. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01530-y · Cited by 1,332
Ferroptosis at the crossroads of cancer-acquired drug resistance and immune evasion
Friedmann Angeli, J. P., Krysko, D. V., & Conrad, M. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-019-0149-1 · Cited by 1,259
GPX4 at the crossroads of lipid homeostasis and ferroptosis
Forcina, G. C., & Dixon, S. J. (2019) · PROTEOMICS · doi:10.1002/pmic.201800311 · Cited by 1,025
BAP1 links metabolic regulation of ferroptosis to tumour suppression
Zhang, Y., Shi, J., Liu, X., Feng, L., Gong, Z., Koppula, P., Sirohi, K., Li, X., Wei, Y., Lee, H., et al. (2018) · Nature Cell Biology · doi:10.1038/s41556-018-0178-0 · Cited by 1,013
Self-citationTsoi, J., Robert, L., Paraiso, K., Galvan, C., Sheu, K. M., Lay, J., Wong, D. J. L., Atefi, M., Shirazi, R., Wang, X., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.03.017 · Cited by 938
Koppula, P., Zhang, Y., Zhuang, L., & Gan, B. (2018) · Cancer Communications · doi:10.1186/s40880-018-0288-x · Cited by 915
Platinum-based drugs: past, present and future
Dilruba, S., & Kalayda, G. V. (2016) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-016-2976-z · Cited by 906
Nedeljković, M., & Damjanović, A. (2019) · Cells · doi:10.3390/cells8090957 · Cited by 870
Ferroptosis in infection, inflammation, and immunity
Chen, X., Kang, R., Kroemer, G., & Tang, D. (2021) · Journal of Experimental Medicine · doi:10.1084/jem.20210518 · Cited by 824
NFS1 undergoes positive selection in lung tumours and protects cells from ferroptosis
Alvarez, S. W., Sviderskiy, V. O., Terzi, E. M., Papagiannakopoulos, T., Moreira, A. L., Adams, S., Sabatini, D. M., Birsoy, K., & Possemato, R. (2017) · Nature · doi:10.1038/nature24637 · Cited by 787
Ferroptosis: A Novel Anti-tumor Action for Cisplatin
Guo, J., Xu, B., Han, Q., Zhou, H., Xia, Y., Gong, C., Dai, X., Li, Z., & Wu, G. (2018) · Cancer Research and Treatment · doi:10.4143/crt.2016.572 · Cited by 777
AMPK-Mediated BECN1 Phosphorylation Promotes Ferroptosis by Directly Blocking System Xc– Activity
Song, X., Zhu, S., Chen, P., Hou, W., Wen, Q., Liu, J., Xie, Y., Liu, J., Klionsky, D. J., Kroemer, G., et al. (2018) · Current Biology · doi:10.1016/j.cub.2018.05.094 · Cited by 746
Cytochrome P450 oxidoreductase contributes to phospholipid peroxidation in ferroptosis
Zou, Y., Li, H., Graham, E. T., Deik, A. A., Eaton, J. K., Wang, W., Sandoval-Gomez, G., Clish, C. B., Doench, J. G., & Schreiber, S. L. (2020) · Nature Chemical Biology · doi:10.1038/s41589-020-0472-6 · Cited by 734
Metallothionein‐1G facilitates sorafenib resistance through inhibition of ferroptosis
Sun, X., Niu, X., Chen, R., He, W., Chen, D., Kang, R., & Tang, D. (2016) · Hepatology · doi:10.1002/hep.28574 · Cited by 703
Nrf2-Keap1 pathway promotes cell proliferation and diminishes ferroptosis
Fan, Z., Wirth, A.-K., Chen, D., Wruck, C. J., Rauh, M., Buchfelder, M., & Savaskan, N. (2017) · Oncogenesis · doi:10.1038/oncsis.2017.65 · Cited by 692
Non-genetic mechanisms of therapeutic resistance in cancer
Marine, J.-C., Dawson, S.-J., & Dawson, M. A. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-020-00302-4 · Cited by 635
Ferroptosis is induced following siramesine and lapatinib treatment of breast cancer cells
Ma, S., Henson, E. S., Chen, Y., & Gibson, S. B. (2016) · Cell Death & Disease · doi:10.1038/cddis.2016.208 · Cited by 622
Tang, D., & Kroemer, G. (2020) · Current Biology · doi:10.1016/j.cub.2020.09.068 · Cited by 605
Iron‐dependent cell death of hepatocellular carcinoma cells exposed to sorafenib
Louandre, C., Ezzoukhry, Z., Godin, C., Barbare, J., Mazière, J., Chauffert, B., & Galmiche, A. (2013) · International Journal of Cancer · doi:10.1002/ijc.28159 · Cited by 602
The challenge of drug resistance in cancer treatment: a current overview
Nikolaou, M., Pavlopoulou, A., Georgakilas, A. G., & Kyrodimos, E. (2018) · Clinical & Experimental Metastasis · doi:10.1007/s10585-018-9903-0 · Cited by 600
HSPA5 Regulates Ferroptotic Cell Death in Cancer Cells
Zhu, S., Zhang, Q., Sun, X., Zeh, H. J., Lotze, M. T., Kang, R., & Tang, D. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-1979 · Cited by 576
Ferroptosis, a novel pharmacological mechanism of anti-cancer drugs
Su, Y., Zhao, B., Zhou, L., Zhang, Z., Shen, Y., Lv, H., AlQudsy, L. H. H., & Shang, P. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.02.015 · Cited by 576
Prominin2 Drives Ferroptosis Resistance by Stimulating Iron Export
Brown, C. W., Amante, J. J., Chhoy, P., Elaimy, A. L., Liu, H., Zhu, L. J., Baer, C. E., Dixon, S. J., & Mercurio, A. M. (2019) · Developmental Cell · doi:10.1016/j.devcel.2019.10.007 · Cited by 575
p53 in ferroptosis regulation: The new weapon for the old guardian
Liu, Y., & Gu, W. (2022) · Cell Death & Differentiation · doi:10.1038/s41418-022-00943-y · Cited by 540
Nrf2 inhibition reverses resistance to GPX4 inhibitor-induced ferroptosis in head and neck cancer
Shin, D., Kim, E. H., Lee, J., & Roh, J.-L. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.10.426 · Cited by 534
Ouyang, S., Li, H., Lou, L., Huang, Q., Zhang, Z., Mo, J., Li, M., Lu, J., Zhu, K., Chu, Y., et al. (2022) · Redox Biology · doi:10.1016/j.redox.2022.102317 · Cited by 507
Self-citationFerroptosis, radiotherapy, and combination therapeutic strategies
Lei, G., Mao, C., Yan, Y., Zhuang, L., & Gan, B. (2021) · Protein & Cell · doi:10.1007/s13238-021-00841-y · Cited by 504
Du, J., Wang, T., Li, Y., Zhou, Y., Wang, X., Yu, X., Ren, X., An, Y., Wu, Y., Sun, W., et al. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.12.011 · Cited by 487
Self-citationYAP/TAZ and ATF4 drive resistance to Sorafenib in hepatocellular carcinoma by preventing ferroptosis
Gao, R., Kalathur, R. K. R., Coto‐Llerena, M., Ercan, C., Buechel, D., Shuang, S., Piscuoglio, S., Dill, M. T., Camargo, F. D., Christofori, G., et al. (2021) · EMBO Molecular Medicine · doi:10.15252/emmm.202114351 · Cited by 484
Sorafenib induces ferroptosis in human cancer cell lines originating from different solid tumors.
Lachaier, E., Louandre, C., Godin, C., Saidak, Z., Baert, M., Diouf, M., Chauffert, B., & Galmiche, A. (2014) · PubMed · Cited by 477
Breakdown of an Ironclad Defense System: The Critical Role of NRF2 in Mediating Ferroptosis
Anandhan, A., Dodson, M., Schmidlin, C. J., Liu, P., & Zhang, D. D. (2020) · Cell Chemical Biology · doi:10.1016/j.chembiol.2020.03.011 · Cited by 442
Wnt/beta-catenin signaling confers ferroptosis resistance by targeting GPX4 in gastric cancer
Wang, Y., Zheng, L., Shang, W., Yang, Z., Li, T., Liu, F., Shao, W., Lv, L., Chai, L., Qu, L., et al. (2022) · Cell Death & Differentiation · doi:10.1038/s41418-022-01008-w · Cited by 422
Self-citationATF4 promotes angiogenesis and neuronal cell death and confers ferroptosis in a xCT-dependent manner
Chen, D., Fan, Z., Rauh, M., Buchfelder, M., Eyupoglu, I. Y., & Savaskan, N. (2017) · Oncogene · doi:10.1038/onc.2017.146 · Cited by 421
Molecular mechanisms of cisplatin resistance in cervical cancer
Zhu, X., Zhu, H., Luo, H., Zhang, W., Shen, Z., & Hu, X. (2016) · Drug Design, Development and Therapy · doi:10.2147/dddt.s106412 · Cited by 407
Hu, K., Li, K., Lv, J., Feng, J., Chen, J., Wu, H., Cheng, F., Jiang, W., Wang, J., Pei, H., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci124049 · Cited by 404
Self-citationChen, P., Li, X., Zhang, R., Liu, S., Xiang, Y., Zhang, M., Chen, X., Pan, T., Yan, L., Feng, J., et al. (2020) · Theranostics · doi:10.7150/thno.44705 · Cited by 403
Self-citationHadian, K., & Stockwell, B. R. (2020) · Cell · doi:10.1016/j.cell.2020.04.039 · Cited by 377
Lou, J.-S., Zhao, L.-P., Huang, Z.-H., Chen, X.-Y., Xu, J.-T., TAI, W. C.-S., Tsim, K. W. K., Chen, Y.-T., & Xie, T. (2021) · Phytomedicine · doi:10.1016/j.phymed.2020.153370 · Cited by 346
Cell death in pancreatic cancer: from pathogenesis to therapy
Chen, X., Zeh, H. J., Kang, R., Kroemer, G., & Tang, D. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00486-6 · Cited by 336
NRF2 Is a Major Target of ARF in p53-Independent Tumor Suppression
Chen, D., Tavana, O., Chu, B., Erber, L., Chen, Y., Baer, R., & Gu, W. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.09.009 · Cited by 317
Artesunate synergizes with sorafenib to induce ferroptosis in hepatocellular carcinoma
Li, Z.-J., Dai, H.-Q., Huang, X.-W., Feng, J., Deng, J.-H., Wang, Z.-X., Yang, X.-M., Liu, Y.-J., Wu, Y., Chen, P.-H., et al. (2021) · Acta Pharmacologica Sinica · doi:10.1038/s41401-020-0478-3 · Cited by 315
Lim, J. K. M., Delaidelli, A., Minaker, S. W., Zhang, H.-F., Colovic, M., Yang, H., Negri, G. L., von Karstedt, S., Lockwood, W. W., Schaffer, P., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1821323116 · Cited by 308
Zhang, X., Sui, S., Wang, L., Li, H., Zhang, L., Xu, S., & Zheng, X. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29232 · Cited by 293
Chemotherapy Resistance in Advanced Ovarian Cancer Patients
Pokhriyal, R., Hariprasad, R., Kumar, L., & Hariprasad, G. (2019) · Biomarkers in Cancer · doi:10.1177/1179299x19860815 · Cited by 283
Fu, D., Wang, C., Yu, L., & Yu, R. (2021) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-021-00271-y · Cited by 283
Li, H., Yang, P., Wang, J., Zhang, J., Ma, Q., Jiang, Y., Wu, Y., Han, T., & Xiang, D. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-021-01223-x · Cited by 273
The Role of Cystine/Glutamate Antiporter SLC7A11/xCT in the Pathophysiology of Cancer
Jyotsana, N., Ta, K. T., & DelGiorno, K. E. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.858462 · Cited by 272
Stem Cell Factor SOX2 Confers Ferroptosis Resistance in Lung Cancer via Upregulation of SLC7A11
Wang, X., Chen, Y., Wang, X., Tian, H., Wang, Y., Jin, J., Shan, Z., Liu, Y., Cai, Z., Tong, X., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-21-0567 · Cited by 264
Self-citationKim, E. H., Shin, D., Lee, J., Jung, A. R., & Roh, J.-L. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.06.018 · Cited by 261
Song, Z., Jia, G., Ma, P., & Cang, S. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119399 · Cited by 260
Buccarelli, M., Marconi, M., Pacioni, S., De Pascalis, I., D’Alessandris, Q. G., Martini, M., Ascione, B., Malorni, W., Larocca, L. M., Pallini, R., et al. (2018) · Cell Death & Disease · doi:10.1038/s41419-018-0864-7 · Cited by 257
Dihydroartemisinin: A Potential Natural Anticancer Drug
Dai, X., Zhang, X., Chen, W., Chen, Y., Zhang, Q., Mo, S., & Lu, J. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.50364 · Cited by 252
Identification of Frataxin as a regulator of ferroptosis
Du, J., Zhou, Y., Li, Y., Xia, J., Chen, Y., Chen, S., Wang, X., Sun, W., Wang, T., Ren, X., et al. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101483 · Cited by 243
Self-citationFrizzled-7 Identifies Platinum-Tolerant Ovarian Cancer Cells Susceptible to Ferroptosis
Wang, Y., Zhao, G., Condello, S., Huang, H., Cardenas, H., Tanner, E. J., Wei, J., Ji, Y., Li, J., Tan, Y., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-1488 · Cited by 243
Self-citationChen, T.-C., Chuang, J.-Y., Ko, C.-Y., Kao, T.-J., Yang, P.-Y., Yu, C.-H., Liu, M.-S., Hu, S.-L., Tsai, Y.-T., Chan, H., et al. (2020) · Redox Biology · doi:10.1016/j.redox.2019.101413 · Cited by 228
Zou, Y., Zheng, S., Xie, X., Ye, F., Hu, X., Tian, Z., Yan, S.-M., Yang, L., Kong, Y., Tang, Y., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30217-7 · Cited by 226
Paradoxical effects of chemotherapy on tumor relapse and metastasis promotion
D’Alterio, C., Scala, S., Sozzi, G., Roz, L., & Bertolini, G. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.08.019 · Cited by 219
RSL3 Drives Ferroptosis through NF‐κ B Pathway Activation and GPX4 Depletion in Glioblastoma
Li, S., He, Y., Chen, K., Sun, J., Zhang, L., He, Y., Yu, H., & Li, Q. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/2915019 · Cited by 213
MYCN mediates cysteine addiction and sensitizes neuroblastoma to ferroptosis
Alborzinia, H., Flórez, A. F., Kreth, S., Brückner, L. M., Yildiz, U., Gartlgruber, M., Odoni, D. I., Poschet, G., Garbowicz, K., Shao, C., et al. (2022) · Nature Cancer · doi:10.1038/s43018-022-00355-4 · Cited by 213
Lu, Y., Chan, Y.-T., Tan, H.-Y., Zhang, C., Guo, W., Xu, Y., Sharma, R., Chen, Z.-S., Zheng, Y.-C., Wang, N., et al. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-02208-x · Cited by 211
Daher, B., Parks, S. K., Durivault, J., Cormerais, Y., Baidarjad, H., Tambutte, E., Pouysségur, J., & Vučetić, M. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-3855 · Cited by 200
Du, J., Wang, X., Li, Y., Ren, X., Zhou, Y., Hu, W., Zhou, C., Jing, Q., Yang, C., Wang, L., et al. (2021) · Cell Death & Disease · doi:10.1038/s41419-021-03996-y · Cited by 197
Self-citationGhafouri-Fard, S., Abak, A., Tondro Anamag, F., Shoorei, H., Fattahi, F., Javadinia, S. A., Basiri, A., & Taheri, M. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.658636 · Cited by 193
Hasegawa, M., Takahashi, H., Rajabi, H., Alam, M., Suzuki, Y., Yin, L., Tagde, A., Maeda, T., Hiraki, M., Sukhatme, V. P., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.7598 · Cited by 191
Sorafenib fails to trigger ferroptosis across a wide range of cancer cell lines
Zheng, J., Sato, M., Mishima, E., Sato, H., Proneth, B., & Conrad, M. (2021) · Cell Death & Disease · doi:10.1038/s41419-021-03998-w · Cited by 190
Xc− inhibitor sulfasalazine sensitizes colorectal cancer to cisplatin by a GSH-dependent mechanism
Ma, M.-Z., Chen, G., Wang, P., Lu, W.-H., Zhu, C.-F., Song, M., Yang, J., Wen, S., Xu, R.-H., Hu, Y., et al. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.07.031 · Cited by 186
Shin, D., Lee, J., You, J. H., Kim, D., & Roh, J.-L. (2020) · Redox Biology · doi:10.1016/j.redox.2019.101418 · Cited by 178
Jiang, M., Qiao, M., Zhao, C., Deng, J., Li, X., & Zhou, C. (2020) · Translational Lung Cancer Research · doi:10.21037/tlcr-20-341 · Cited by 172
Chrysin: Perspectives on Contemporary Status and Future Possibilities as Pro-Health Agent
Stompor, M., Bajek-Bil, A., & Machaczka, M. (2021) · Nutrients · doi:10.3390/nu13062038 · Cited by 170
Iron and leukemia: new insights for future treatments
Wang, F., Lv, H., Zhao, B., Zhou, L., Wang, S., Luo, J., Liu, J., & Shang, P. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1397-3 · Cited by 166
ACSL4 is a predictive biomarker of sorafenib sensitivity in hepatocellular carcinoma
Feng, J., Lu, P.-Z., Zhu, G.-Z., Hooi, S. C., Wu, Y., Huang, X.-W., Dai, H.-Q., Chen, P.-H., Li, Z.-J., Su, W.-J., et al. (2021) · Acta Pharmacologica Sinica · doi:10.1038/s41401-020-0439-x · Cited by 166
Huang, W., Chen, K., Lu, Y., Zhang, D., Cheng, Y., Li, L., Huang, W., He, G., Liao, H., Cai, L., et al. (2021) · Neoplasia · doi:10.1016/j.neo.2021.11.002 · Cited by 162
Deubiquitinase USP35 modulates ferroptosis in lung cancer via targeting ferroportin
Tang, Z., Jiang, W., Mao, M., Zhao, J., Chen, J., & Cheng, N. (2021) · Clinical and Translational Medicine · doi:10.1002/ctm2.390 · Cited by 161
Self-citationLi, Y., Yan, H., Xu, X., Liu, H., Wu, C., & Zhao, L. (2019) · Oncology Letters · doi:10.3892/ol.2019.11066 · Cited by 158
Self-citationThe role of ferroptosis in lung cancer
Wu, S., Zhu, C., Tang, D., Dou, Q. P., Shen, J., & Chen, X. (2021) · Biomarker Research · doi:10.1186/s40364-021-00338-0 · Cited by 144
Temozolomide toxicity operates in a xCT/SLC7a11 dependent manner and is fostered by ferroptosis
Sehm, T., Rauh, M., Wiendieck, K., Buchfelder, M., Eyüpoglu, I. Y., & Savaskan, N. E. (2016) · Oncotarget · doi:10.18632/oncotarget.11858 · Cited by 142
Baek, S., Choi, C., Ahn, S. H., Lee, J. W., Gong, G., Ryu, J., Oh, S. J., Bacher-Stier, C., Fels, L., Koglin, N., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0214 · Cited by 141
Houessinon, A., François, C., Sauzay, C., Louandre, C., Mongélard, G., Godin, C., Bodeau, S., Takahashi, S., Saidak, Z., Gutierrez, L., et al. (2016) · Molecular Cancer · doi:10.1186/s12943-016-0526-2 · Cited by 138
Sun, S., Gao, T., Pang, B., Su, X., Guo, C., Zhang, R., & Pang, Q. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04524-2 · Cited by 137
Capozzi, M., Divitiis, C. D., Ottaiano, A., von Arx, C., Scala, S., Tatangelo, F., Delrio, P., & Tafuto, S. (2019) · Cancer Management and Research · doi:10.2147/cmar.s188316 · Cited by 136
NRF2 and glutathione are key resistance mediators to temozolomide in glioma and melanoma cells
Rocha, C. R. R., Kajitani, G. S., Quinet, A., Fortunato, R. S., & Menck, C. F. M. (2016) · Oncotarget · doi:10.18632/oncotarget.10129 · Cited by 135
Mbaveng, A. T., Ndontsa, B. L., Kuete, V., Nguekeu, Y. M. M., Çelik, İ., Mbouangouere, R., Tane, P., & Efferth, T. (2018) · Phytomedicine · doi:10.1016/j.phymed.2018.03.035 · Cited by 135
de Souza, I., Monteiro, L. K. S., Guedes, C. B., Silva, M. M., Andrade-Tomaz, M., Contieri, B., Latância, M. T., Mendes, D., Porchia, B. F. M. M., Lazarini, M., et al. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05044-9 · Cited by 135
Disruption of xCT inhibits cell growth via the ROS/autophagy pathway in hepatocellular carcinoma
Guo, W., Zhao, Y., Zhang, Z., Tan, N., Zhao, F., Ge, C., Liang, L., Jia, D., Chen, T., Yao, M., et al. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.07.024 · Cited by 134
DNA Topoisomerase Inhibitors: Trapping a DNA-Cleaving Machine in Motion
Bax, B. D., Murshudov, G. N., Maxwell, A., & Germe, T. R. (2019) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.07.008 · Cited by 134
Chen, Y., Li, L., Lan, J., Cui, Y., Rao, X., Zhao, J., Xing, T., Ju, G., Song, G., Lou, J., et al. (2022) · Molecular Cancer · doi:10.1186/s12943-021-01466-9 · Cited by 134
Datta, J., Majumder, S., Kutay, H., Motiwala, T., Frankel, W. L., Costa, R. H., Cha, H. C., MacDougald, O. A., Jacob, S. T., & Ghoshal, K. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4433 · Cited by 132
Sun, Y., Qiao, Y., Liu, Y., Zhou, J., Wang, X., Zheng, H., Xu, Z., Zhang, J., Zhou, Y., Qian, L., et al. (2021) · Redox Biology · doi:10.1016/j.redox.2021.101977 · Cited by 131
Lee, J., You, J. H., Shin, D., & Roh, J. (2020) · Theranostics · doi:10.7150/thno.46903 · Cited by 130
Chan, D. W., Yung, M. M. H., Chan, Y.-S., Yang, X., Yang, H., Xu, D., Zhan, J., Chan, K. K. L., Ng, T., & Ngan, H. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105157 · Cited by 129
Iseda, N., Itoh, S., Toshida, K., Tomiyama, T., Morinaga, A., Shimokawa, M., Shimagaki, T., Wang, H., Kurihara, T., Toshima, T., et al. (2022) · Cancer Science · doi:10.1111/cas.15378 · Cited by 127
Self-citationPoly(rC)-binding protein 1 represses ferritinophagy-mediated ferroptosis in head and neck cancer
Lee, J., You, J. H., & Roh, J. (2022) · Redox Biology · doi:10.1016/j.redox.2022.102276 · Cited by 125
Emerging role of ferroptosis in breast cancer: New dawn for overcoming tumor progression
Sui, S., Xu, S., & Pang, D. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107992 · Cited by 120
A Potential Mechanism of Temozolomide Resistance in Glioma–Ferroptosis
Hu, Z., Mi, Y., Qian, H., Guo, N., Yan, A., Zhang, Y., & Gao, X. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00897 · Cited by 116
PGRMC1-dependent lipophagy promotes ferroptosis in paclitaxel-tolerant persister cancer cells
You, J. H., Lee, J., & Roh, J. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-02168-2 · Cited by 112
Liu, W., Zhou, Y., Duan, W., Song, J., Wei, S., Xia, S., Wang, Y., Du, X., Li, E., Ren, C., et al. (2021) · Clinical and Translational Medicine · doi:10.1002/ctm2.517 · Cited by 111
Self-citationBi, G., Liang, J., Zhao, M., Zhang, H., Jin, X. Y., Lu, T., Zheng, Y., Bian, Y., Chen, Z., Huang, Y., et al. (2022) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2022.03.020 · Cited by 105
Wang, Q., Guo, Y., Wang, W., Liu, B., Yang, G., Xu, Z., Li, J., & Liu, Z. (2020) · Experimental Cell Research · doi:10.1016/j.yexcr.2020.112453 · Cited by 104
Emerging cellular and molecular mechanisms underlying anticancer indications of chrysin
Talebi, M., Talebi, M., Farkhondeh, T., Simal‐Gándara, J., Kopustinskienė, D. M., Bernatonienė, J., & Samarghandian, S. (2021) · Cancer Cell International · doi:10.1186/s12935-021-01906-y · Cited by 103
Cystine uptake inhibition potentiates front-line therapies in acute myeloid leukemia
Pardieu, B., Pasanisi, J., Ling, F., Bello, R. D., Penneroux, J., Su, A. H., Joudinaud, R., Chat, L., Wu, H.-C., Duchmann, M., et al. (2022) · Leukemia · doi:10.1038/s41375-022-01573-6 · Cited by 102
Ferroptosis, necroptosis, and pyroptosis in the occurrence and development of ovarian cancer
Zhang, C., & Liu, N. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.920059 · Cited by 102
Zhou, X., Zou, L., Chen, W., Yang, T., Luo, J., Wu, K., Shu, F., Tan, X., Yu, Y., Cen, S., et al. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105305 · Cited by 100
KDM4A-mediated histone demethylation of SLC7A11 inhibits cell ferroptosis in osteosarcoma
Chen, M., Jiang, Y., & Sun, Y. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.02.137 · Cited by 99
Mbaveng, A. T., Fotso, G. W., Ngnintedo, D., Kuete, V., Ngadjui, B. T., Keumedjio, F., Andrae‐Marobela, K., & Efferth, T. (2017) · Phytomedicine · doi:10.1016/j.phymed.2017.12.016 · Cited by 98
The paradigm of drug resistance in cancer: an epigenetic perspective
Adhikari, S., Bhattacharya, A., Adhikary, S., Singh, V., Gadad, S. S., Roy, S., & Das, C. (2022) · Bioscience Reports · doi:10.1042/bsr20211812 · Cited by 95
Okazaki, S., Shintani, S., Hirata, Y., Suina, K., Semba, T., Yamasaki, J., Umene, K., Ishikawa, M., Saya, H., & Nagano, O. (2018) · Oncotarget · doi:10.18632/oncotarget.26112 · Cited by 94
Zhang, X., Guo, Y., Li, H., & Han, L. (2021) · Journal of Cancer · doi:10.7150/jca.58500 · Cited by 91
Cheng, Q., Bao, L., Li, M., Chang, K., & Yi, X. (2021) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.14779 · Cited by 90
Targeting Ferroptosis Pathway to Combat Therapy Resistance and Metastasis of Cancer
Liu, X., Zhang, Y., Wu, X., Xu, F., Ma, H., Wu, M., & Xia, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.909821 · Cited by 90
Self-citationArtesunate induces ferroptosis via modulation of p38 and ERK signaling pathway in glioblastoma cells
Song, Q., Peng, S., Che, F., & Zhu, X. (2022) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2022.01.007 · Cited by 89
Novel Insights on Lipid Metabolism Alterations in Drug Resistance in Cancer
Yang, R., Yi, M., & Xiang, B. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.875318 · Cited by 85
Zheng, X., Chen, W., Yi, J., Wan, L., Liu, J.-Y., Fu, W.-Q., Ren, L., Li, S., Ge, B.-B., Yang, Y., et al. (2022) · Acta Pharmacologica Sinica · doi:10.1038/s41401-022-00917-3 · Cited by 84
Self-citationFerroptosis and Tumor Drug Resistance: Current Status and Major Challenges
Nie, Z., Chen, M., Gao, Y., Huang, D., Cao, H., Peng, Y., Guo, N., Wang, F., & Zhang, S. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.879317 · Cited by 84
Zhou, L., Yang, C., Zhong, W., Wang, Q., Zhang, D., Zhang, J., Xie, S., & Xu, M. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114813 · Cited by 82
Long Non-Coding RNA in Gastric Cancer: Mechanisms and Clinical Implications for Drug Resistance
Liu, Y., Ao, X., Wang, Y., Li, X., & Wang, J. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.841411 · Cited by 82
Self-citationPropofol Augments Paclitaxel-Induced Cervical Cancer Cell Ferroptosis In Vitro
Zhao, M., Liu, P., Sun, C., Pei, L., & Huang, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.816432 · Cited by 77
Tang, Z., Dong, H., Li, T. X., Wang, N., Wei, X., Wu, H., Liu, Y., Wang, W., Guo, Z., & Xiao, X. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/5192271 · Cited by 76
Ferroptosis and its Role in Gastric Cancer
Gu, R., Xia, Y., Li, P., Zou, D., Lu, K., Ren, L., Zhang, H., & Sun, Z. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.860344 · Cited by 76
Emerging Mechanisms and Targeted Therapy of Ferroptosis in Neurological Diseases and Neuro-oncology
Wang, Y., Tang, B., Zhu, J., Yu, J., Hui, J., Xia, S., & Ji, J. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.72251 · Cited by 75
Self-citationFerroptosis: At the Crossroad of Gemcitabine Resistance and Tumorigenesis in Pancreatic Cancer
Yang, J., Xu, J., Zhang, B., Tan, Z., Meng, Q., Hua, J., Liu, J., Wang, W., Shi, S., Yu, X., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222010944 · Cited by 73
The oxido-metabolic driver ATF4 enhances temozolamide chemo-resistance in human gliomas
Chen, D., Rauh, M., Buchfelder, M., Eyüpoglu, I. Y., & Savaskan, N. E. (2017) · Oncotarget · doi:10.18632/oncotarget.17737 · Cited by 72
Han, N., Li, L., Peng, X., Ma, Q., Yang, Z., Wang, X., Li, J., Li, Q.-R., Yu, T., Xu, H., et al. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.174797 · Cited by 72
Ferroptosis promotes anti‐tumor immune response by inducing immunogenic exposure in HNSCC
Zhao, Y., Lian, J., Lan, Z., Zou, K., Wang, W., & Yu, G. (2021) · Oral Diseases · doi:10.1111/odi.14077 · Cited by 71
SIRT6 silencing overcomes resistance to sorafenib by promoting ferroptosis in gastric cancer
Cai, S., Fu, S., Zhang, W., Yuan, X., Cheng, Y., & Fang, J. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.08.080 · Cited by 69
Dihydroartemisinin: A Potential Drug for the Treatment of Malignancies and Inflammatory Diseases
Yu, R., Jin, G., & Fujimoto, M. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.722331 · Cited by 68
Lu, T., Zhang, Z., Pan, X., Zhang, J., Wang, X., Wang, M., Li, H., Yan, M., & Chen, W. (2021) · Journal of Oral Pathology and Medicine · doi:10.1111/jop.13267 · Cited by 68
Molecular Mechanisms of Ferroptosis and Its Roles in Hematologic Malignancies
Zhao, Y., Huang, Z., & Peng, H. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.743006 · Cited by 67
Hu, Z., Wen, Y., Ma, R., Chen, L., Zeng, X., Wen, W., & Sun, W. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.727762 · Cited by 65
History and emerging trends in chemotherapy for gastric cancer
Yamashita, K., Hosoda, K., Niihara, M., & Hiki, N. (2021) · Annals of Gastroenterological Surgery · doi:10.1002/ags3.12439 · Cited by 64
Artesunate: A review of its therapeutic insights in respiratory diseases
Zhang, J., Li, Y., Wan, J., Zhang, M., Li, C., & Lin, J. (2022) · Phytomedicine · doi:10.1016/j.phymed.2022.154259 · Cited by 64
Self-citationGavrilaș, L. I., Cruceriu, D., Mocan, A., Loghin, F., Miere, D., & Bălăcescu, O. (2022) · Biomedicines · doi:10.3390/biomedicines10081948 · Cited by 64
The critical role of ferritinophagy in human disease
Liu, M., Kong, N., Zhang, G., Xu, Q. L., Xu, Y. Y., Ke, P., & Liu, C. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.933732 · Cited by 64
Sugiyama, A., Ohta, T., Obata, M., Takahashi, K., Seino, M., & Nagase, S. (2020) · Oncology Letters · doi:10.3892/ol.2020.11813 · Cited by 62
GALNT14 Regulates Ferroptosis and Apoptosis of Ovarian Cancer Through the EGFR/mTOR Pathway
Li, H.-W., Liu, M., Jiang, X., Song, T., Feng, S., Wu, J., Deng, P., & Wang, X. (2021) · Future Oncology · doi:10.2217/fon-2021-0883 · Cited by 62
Hacıoğlu, C., & Kar, F. (2022) · Metabolic Brain Disease · doi:10.1007/s11011-022-00983-w · Cited by 61
PCDHB14 promotes ferroptosis and is a novel tumor suppressor in hepatocellular carcinoma
Liu, Y., Ouyang, L., Mao, C., Chen, Y., Li, T., Liu, N., Wang, Z., Lai, W., Zhou, Y., Cao, Y., et al. (2022) · Oncogene · doi:10.1038/s41388-022-02370-2 · Cited by 61
From Iron Chelation to Overload as a Therapeutic Strategy to Induce Ferroptosis in Leukemic Cells
Grignano, É., Birsen, R., Chapuis, N., & Bouscary, D. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.586530 · Cited by 60
Resistance of Lenvatinib in Hepatocellular Carcinoma
Xu, Q., Huang, D., Guo, J., & Zhao, J. (2022) · Current Cancer Drug Targets · doi:10.2174/1568009622666220428111327 · Cited by 60
Zhang, Y., Tan, Y., Liu, S., Yin, H., Duan, J., Fan, L., Zhao, X., & Jiang, B. (2022) · Toxicology Mechanisms and Methods · doi:10.1080/15376516.2022.2075297 · Cited by 60
Current Possibilities of Gynecologic Cancer Treatment with the Use of Immune Checkpoint Inhibitors
Grywalska, E., Sobstyl, M., Putowski, L. T., & Roliński, J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20194705 · Cited by 59
Cui, Z., Wang, H., Li, S., Qin, T., Shi, H., Ma, J., Li, L., Yu, G., Jiang, T., & Li, C. (2021) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2021.09.008 · Cited by 59
Self-citationTRIB2 desensitizes ferroptosis via βTrCP-mediated TFRC ubiquitiantion in liver cancer cells
Guo, S., Chen, Y., Xue, X., Yang, Y., Wang, Y., Qiu, S., Cui, J., Zhang, X., Ma, L., Qiao, Y., et al. (2021) · Cell Death Discovery · doi:10.1038/s41420-021-00574-1 · Cited by 58
Self-citationZhang, L., & Wang, H. (2017) · Pharmacological Reports · doi:10.1016/j.pharep.2017.07.003 · Cited by 57
Self-citationGonzalez‐Molina, J., Moyano‐Galceran, L., Single, A., Gultekin, O., Alsalhi, S., & Lehti, K. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.03.012 · Cited by 55
Cisplatin Promotes the Efficacy of ICI Therapy by Inducing Ferroptosis and Activating Neutrophils
Zhou, Z., Zhao, Y., Chen, S. X., Cui, G., Fu, W., Li, S., Lin, X., & Hu, H. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.870178 · Cited by 55
Cisplatin synergizes with PRLX93936 to induce ferroptosis in non-small cell lung cancer cells
Liang, Z., Zhao, W., Li, X., Wang, L., Meng, L., & Yu, R. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.06.088 · Cited by 54
Ferroptosis: A Trusted Ally in Combating Drug Resistance in Cancer
Özkan, E., & Bakar‐Ates, F. (2021) · Current Medicinal Chemistry · doi:10.2174/0929867328666210810115812 · Cited by 54
Han, L., Li, L., & Wu, G. (2022) · Molecular and Cellular Probes · doi:10.1016/j.mcp.2022.101821 · Cited by 54
MicroRNA-147a Targets SLC40A1 to Induce Ferroptosis in Human Glioblastoma
Xu, P., Ge, F., Li, W., Xu, Z., Wang, X., Shen, J.-L., Xu, A., & Hao, R. (2022) · Analytical Cellular Pathology · doi:10.1155/2022/2843990 · Cited by 52
Xu, B., Zhu, W.-J., Peng, Y., & Cheng, S. (2021) · Translational Cancer Research · doi:10.21037/tcr-21-227 · Cited by 48
Gao, C., Xiao, F., Zhang, L., Sun, Y., Wang, L., Liu, X., Sun, H., Xie, Z., Liang, Y., Xu, Q., et al. (2022) · Annals of Translational Medicine · doi:10.21037/atm-21-6909 · Cited by 48
Wang, R., Su, Q., Yin, H., Wu, D., Lv, C., & Yan, Z. (2021) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2021.105948 · Cited by 47
The Role of microRNAs in the Cisplatin- and Radio-Resistance of Cervical Cancer
Masadah, R., Rauf, S., Pratama, M. Y., Tiribelli, C., & Pascut, D. (2021) · Cancers · doi:10.3390/cancers13051168 · Cited by 45
Vulnerability of Triple-Negative Breast Cancer to Saponin Formosanin C-Induced Ferroptosis
Chen, H., Tang, H.-H., Hsu, W., Wu, S., Cheng, W., Wang, B.-Y., & Su, C. (2022) · Antioxidants · doi:10.3390/antiox11020298 · Cited by 45
Monteleone, L., Speciale, A., Valenti, G. E., Traverso, N., Ravera, S., Garbarino, O., Leardi, R., Farinini, E., Roveri, A., Ursini, F., et al. (2021) · Antioxidants · doi:10.3390/antiox10050691 · Cited by 44
Chang, M., Tsai, L., Nakagawa‐Goto, K., Lee, K., & Shyur, L. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106148 · Cited by 44
Sun, C., Liu, P., Pei, L., Zhao, M., & Huang, Y. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.837974 · Cited by 44
Yang, F., Wang, C., Zhu, J., Gai, Q., Mao, M., He, J., Qin, Y., Yao, X., Wang, Y., Lu, H., et al. (2022) · Laboratory Investigation · doi:10.1038/s41374-022-00779-7 · Cited by 43
Self-citationShang, M., Weng, L., Xu, G., Wu, S., Liu, B., Yin, X., Mao, A., Zou, X., & Wang, Z.-M. (2021) · Journal of Cellular Physiology · doi:10.1002/jcp.30346 · Cited by 41
Ferroptosis Involvement in Glioblastoma Treatment
Mitre, A. O., Florian, I. A., Buruiană, A., Boer, A., Moldovan, I. M., Şoriţău, O., Florian, I. Ş., & Șușman, S. (2022) · Medicina · doi:10.3390/medicina58020319 · Cited by 41
CRL2-KLHDC3 E3 ubiquitin ligase complex suppresses ferroptosis through promoting p14ARF degradation
Zhang, P., Gao, K., Zhang, L., Sun, H., Zhao, X., Liu, Y., Lv, Z., Shi, Q., Chen, Y., Jiao, D., et al. (2021) · Cell Death and Differentiation · doi:10.1038/s41418-021-00890-0 · Cited by 40
Self-citationFerroptosis in Lung Cancer: From Molecular Mechanisms to Prognostic and Therapeutic Opportunities
Tabnak, P., HajiEsmailPoor, Z., & Soraneh, S. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.792827 · Cited by 37
Ferroptosis: Redox Imbalance and Hematological Tumorigenesis
Lan, H., Gao, Y., Zhao, Z., Mei, Z., & Wang, F. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.834681 · Cited by 36
Cui, Z., Li, D., Zhao, J., & Chen, K. (2022) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2022.03.003 · Cited by 35
FAM98A promotes resistance to 5-fluorouracil in colorectal cancer by suppressing ferroptosis
He, Z., Yang, J.-B., Sui, C., Zhang, P., Wang, T., Mou, T., Sun, K., Wang, Y., Xu, Z., Li, G., et al. (2022) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2022.109216 · Cited by 33
Self-citationWu, Y., Wang, D., Lou, Y., Liu, X., Huang, P., Jin, M., & Huang, G. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112927 · Cited by 32
Yang, S., Zhang, D., Shen, N., Wang, G., Tang, Z., & Chen, X. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.27421 · Cited by 30
Ferroptosis and Its Potential Role in Lung Cancer: Updated Evidence from Pathogenesis to Therapy
Chen, K., Zhang, S., Jiao, J., & Zhao, S. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s347955 · Cited by 30
Lara, L. I., Fenner, S., Ratcliffe, S. J., Isidro‐Llobet, A., Hann, M. M., Bax, B. D., & Osheroff, N. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky072 · Cited by 28
Fan, X., Ou, Y., Liu, H., Zhan, L., Zhu, X., Cheng, M., Li, Q., Yin, D., & Liao, L. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.732211 · Cited by 28
Dihydroartemisinin Triggers Ferroptosis in Multidrug-Resistant Leukemia Cells
Zhang, X., Ai, Z., Zhang, Z., Dong, R., Wang, L., Jin, S., & Wei, H. (2022) · DNA and Cell Biology · doi:10.1089/dna.2021.1145 · Cited by 28
Lin, Q., Hou, S., Dai, Y., Jiang, N., & Lin, Y. (2020) · Neuroreport · doi:10.1097/wnr.0000000000001467 · Cited by 24
Lü, W., Wu, Y., Huang, S., & Zhang, D. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.755486 · Cited by 23
Yao, L., Li, J., Zhang, X., Zhou, L., & Hu, K. (2022) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13945 · Cited by 23
Anti-cancer effects of fenbendazole on 5-fluorouracil-resistant colorectal cancer cells
Park, D., Lee, J.-H., & Yoon, S.-P. (2022) · The Korean Journal of Physiology & Pharmacology · doi:10.4196/kjpp.2022.26.5.377 · Cited by 23
Wang, Y., Zhang, L., Yao, C., Ma, Y., & Liu, Y. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/4750671 · Cited by 21
Self-citation
Cited by
Polyunsaturated Fatty Acids Drive Lipid Peroxidation during Ferroptosis
Mortensen, M. S., Ruiz, J., & Watts, J. L. (2023) · Cells · doi:10.3390/cells12050804 · Cited by 312
Cuproptosis: A novel therapeutic target for overcoming cancer drug resistance
Wang, Y., Chen, Y., Zhang, J., Yang, Y., Fleishman, J. S., Wang, Y., Wang, J., Chen, J., Li, Y., & Wang, H. (2024) · Drug Resistance Updates · doi:10.1016/j.drup.2023.101018 · Cited by 256
Self-citationThe role of mesenchymal stem cells in cancer and prospects for their use in cancer therapeutics
Tang, J., Chen, Y., Wang, C., Xia, Y., Yu, T., Tang, M., Meng, K., Yin, L., Yang, Y., Shen, L., et al. (2024) · MedComm · doi:10.1002/mco2.663 · Cited by 31
Metadata
- Authors
- Wang, Y., Wu, X., Ren, Z., Li, Y., Zou, W., Chen, J., & Wang, H.
- Venue
- Drug Resistance Updates
- Publisher
- Elsevier BV
- Published
- 2023-01
- Volume
- 66
- Pages
- 100916
- ISSN
- 1368-7646 (ISSN-L)
- OpenAlex
- W4313560081
- Cited by
- 361
- References
- 207
- FWCI
- 39.61
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.